Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | 305 | 1,092 | 1,341 |
| TOTAL | $N/A | $N/A | $703 | $1,221 | $1,438 |
| Non-Current Assets | |||||
| Intangibles | 0 | 0 | 0 | 0 | 39 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $39 |
| Total Assets | $N/A | $N/A | $703 | $1,221 | $1,477 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 797 | 630 | 245 |
| TOTAL | $N/A | $N/A | $819 | $732 | $246 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 2,644 | 2,584 | 2,475 |
| TOTAL | $N/A | $N/A | $2,644 | $2,584 | $2,475 |
| Total Liabilities | $N/A | $N/A | $3,463 | $3,316 | $2,721 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 54 | 54 | 54 |
| Common Shares | N/A | N/A | 27 | 27 | 27 |
| Retained earnings | N/A | N/A | -193,277 | -192,609 | -191,754 |
| TOTAL | $N/A | $N/A | $-2,760 | $-2,095 | $-1,244 |
| Total Liabilities And Equity | $0 | $0 | $703 | $1,221 | $1,477 |